| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
---|
Phase N/A 1
2 3 4 Trials | | 0 | 112233445566778899110 |
---|
| | | |
---|
| | | |
---|
| | | |
---|
Tremfya (guselkumab) / J&J | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
Monjuvi (tafasitamab-cxix) / Incyte | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
ianalumab (VAY736) / MorphoSys, Novartis | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
gantenerumab (RG1450) / Roche, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
utomilumab (PF-05082566) / Pfizer | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
anetumab ravtansine (BAY 94-9343) / Bayer | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
felzartamab (MOR202) / HIBio | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
otilimab (GSK3196165) / GSK | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
abelacimab (MAA868) / Anthos Therap, Novartis, MorphoSys, Lonza | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
setrusumab (BPS804) / Mereo Biopharma, Ultragenyx | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
tesidolumab (LFG316) / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
xentuzumab (BI-836845) / Boehringer Ingelheim | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
ecleralimab (CSJ117) / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
elgemtumab (LJM-716) / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
pelabresib (CPI-0610) / MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
carlumab (CNTO 888) / J&J, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
HIB210 / HIBio | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
JNJ-42915925 / J&J | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
LKA651 / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
MOR106 / MorphoSys, Galapagos, Novartis | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
NOV-8 / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
befovacimab (BAY 1093884) / Bayer | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
vantictumab (OMP-18R5) / Mereo Biopharma | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
BHQ880 / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
CNTO6785 / J&J, Fontacea | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
lirametostat (CPI-1205) / MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
tarextumab (OMP-59R5) / MorphoSys, Mereo Biopharma | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
tulmimetostat (CPI-0209) / MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
BAY79-4620 / Bayer, MorphoSys, Pfizer | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
BI-1 / Boehringer Ingelheim | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
CLG561 / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
HKT288 / MorphoSys, Novartis | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
MHU650 / Novartis, MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
MOR107 / MorphoSys | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
PCA062 / MorphoSys, Novartis | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
|